{{Rsnum
|rsid=2070665
|Gene=APOA1
|Chromosome=11
|position=116836968
|Orientation=minus
|GMAF=0.1804
|Gene_s=APOA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 84.1 | 15.0 | 0.9
| HCB | 43.8 | 46.0 | 10.2
| JPT | 32.7 | 51.3 | 15.9
| YRI | 78.9 | 19.0 | 2.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 43.8 | 46.0 | 10.2
| CHD | 45.9 | 41.3 | 12.8
| GIH | 43.6 | 47.5 | 8.9
| LWK | 83.6 | 16.4 | 0.0
| MEX | 70.2 | 24.6 | 5.3
| MKK | 81.4 | 16.0 | 2.6
| TSI | 79.4 | 19.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24081495
|Title=Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels
}}

{{PMID Auto
|PMID=20300285
|Title=Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}